Legal & General Group PLC Deciphera Pharmaceuticals, Inc. Transaction History

Legal & General Group PLC

$470 Billion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 15, 2024	SELL	$10.11 - $16.54 $49,629 - $81,194	-4,909 Reduced 10.89%	40,170 $647,000
Q3 2023 Nov 14, 2023	SELL	$12.46 - $15.48 $5,681 - $7,058	-456 Reduced 1.0%	45,079 $573,000
Q2 2023 Aug 14, 2023	BUY	$13.28 - $15.96 $273,833 - $329,095	20,620 Added 82.76%	45,535 $641,000
Q1 2023 May 15, 2023	BUY	$14.26 - $22.1 $85,902 - $133,130	6,024 Added 31.89%	24,915 $384,000
Q4 2022 Feb 14, 2023	BUY	$14.85 - $19.04 $11,196 - $14,356	754 Added 4.16%	18,891 $309,000
Q3 2022 Nov 14, 2022	SELL	$12.38 - $20.23 $83,503 - $136,451	-6,745 Reduced 27.11%	18,137 $336,000
Q2 2022 Aug 22, 2022	BUY	$9.11 - $13.98 $77,316 - $118,648	8,487 Added 51.77%	24,882 $327,000
Q1 2022 May 16, 2022	SELL	$6.87 - $11.11 $119,043 - $192,514	-17,328 Reduced 51.38%	16,395 $152,000
Q4 2021 Feb 14, 2022	BUY	$7.7 - $37.13 $25,155 - $121,303	3,267 Added 10.73%	33,723 $330,000
Q3 2021 Nov 15, 2021	BUY	$26.46 - $37.15 $209,536 - $294,190	7,919 Added 35.14%	30,456 $1.04 Million
Q2 2021 Aug 12, 2021	BUY	$32.73 - $47.95 $7,429 - $10,884	227 Added 1.02%	22,537 $825,000
Q1 2021 May 17, 2021	SELL	$40.39 - $56.73 $2,019 - $2,836	-50 Reduced 0.22%	22,310 $1 Million
Q4 2020 Feb 12, 2021	SELL	$51.77 - $66.18 $1,915 - $2,448	-37 Reduced 0.17%	22,360 $1.28 Million
Q3 2020 Nov 13, 2020	SELL	$43.8 - $58.16 $72,051 - $95,673	-1,645 Reduced 6.84%	22,397 $1.15 Million
Q2 2020 Aug 14, 2020	BUY	$37.05 - $65.03 $448,082 - $786,472	12,094 Added 101.22%	24,042 $1.44 Million
Q1 2020 May 14, 2020	SELL	$33.63 - $69.4 $886,890 - $1.83 Million	-26,372 Reduced 68.82%	11,948 $492,000
Q4 2019 Feb 13, 2020	BUY	$31.7 - $69.93 $1.07 Million - $2.36 Million	33,766 Added 741.46%	38,320 $2.39 Million
Q3 2019 Nov 13, 2019	BUY	$19.95 - $38.85 $35,311 - $68,764	1,770 Added 63.58%	4,554 $155,000
Q2 2019 Aug 14, 2019	BUY	$21.05 - $26.21 $23,933 - $29,800	1,137 Added 69.03%	2,784 $62,000
Q3 2018 Nov 20, 2018	BUY	$33.57 - $42.1 $19,705 - $24,712	587 Added 55.38%	1,647 $64,000
Q2 2018 Aug 10, 2018	SELL	$20.06 - $44.95 $7,462 - $16,721	-372 Reduced 25.98%	1,060 $42,000
Q4 2017 Feb 13, 2018	BUY	$16.54 - $24.2 $23,685 - $34,654	1,432	1,432 $33,000

Others Institutions Holding DCPH

# of Institutions

Shares Held

293K

Call Options Held

500

Put Options Held

View Full List

About Deciphera Pharmaceuticals, Inc.

Ticker DCPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,822,100
Description
Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...

More about DCPH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.

Account